Literature DB >> 10216948

PKR, apoptosis and cancer.

R Jagus1, B Joshi, G N Barber.   

Abstract

The double-stranded (ds) RNA-regulated serine/threonine protein kinase, PKR, is an interferon-inducible enzyme of widespread occurrence in mammalian cells. PKR is activated by dsRNA via a mechanism involving autophosphorylation. Once activated, the enzyme phosphorylates the alpha-subunit of protein synthesis initiation factor eIF2, thereby inhibiting translation. Accumulating data suggest that PKR has additional substrates, and that the kinase may also regulate gene transcription and signal transduction pathways. Although PKR plays an important role in mediating the antiviral effects of interferons, PKR is also implicated in regulating cell proliferation in uninfected cells and may have a tumor suppressor function under normal conditions. Studies of human malignancies and tumor cell lines suggest that, in general, patients bearing tumors with a higher PKR content have a more favorable prognosis. However, in human breast carcinoma cells, dysregulation of PKR may be associated with the establishment or maintenance of the transformed state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216948     DOI: 10.1016/s1357-2725(98)00136-8

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  48 in total

Review 1.  Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor.

Authors:  R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR).

Authors:  Xu Huang; Brian Hutchins; Rekha C Patel
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 3.  Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets.

Authors:  A Shir; A Levitzki
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

4.  GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.

Authors:  Mark E Bernard; Hyun Kim; Hebist Berhane; Michael W Epperly; Darcy Franicola; Xichen Zhang; Frank Houghton; Donna Shields; Hong Wang; Christopher J Bakkenist; Marie-Celine Frantz; Erin M Forbeck; Julie P Goff; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2011-09-22       Impact factor: 2.841

5.  Identification of the heparin-binding domains of the interferon-induced protein kinase, PKR.

Authors:  Stephen Fasciano; Brian Hutchins; Indhira Handy; Rekha C Patel
Journal:  FEBS J       Date:  2005-03       Impact factor: 5.542

6.  Expression of PACT is regulated by Sp1 transcription factor.

Authors:  Stephen Fasciano; Amanda Kaufman; Rekha C Patel
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

7.  Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase.

Authors:  Qiaozhu Su; Shuo Wang; Dionissios Baltzis; Li-Ke Qu; Andrew Hoi-Tao Wong; Antonis E Koromilas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

8.  Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis.

Authors:  A L Scarim; M Arnush; L A Blair; J Concepcion; M R Heitmeier; D Scheuner; R J Kaufman; J Ryerse; R M Buller; J A Corbett
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

9.  Protein kinase RNA/FADD/caspase-8 pathway mediates the proapoptotic activity of the RNA-binding protein human antigen R (HuR).

Authors:  Christopher von Roretz; Imed-Eddine Gallouzi
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

10.  MicroRNA-29b regulates ethanol-induced neuronal apoptosis in the developing cerebellum through SP1/RAX/PKR cascade.

Authors:  Yuanlin Qi; Mingfang Zhang; Hui Li; Jacqueline A Frank; Lu Dai; Huijuan Liu; Gang Chen
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.